Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neoplasm Metastasis × pegfilgrastim × Clear all

Phase

Phase 1 3 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 4 Lymphoma 4 Breast Neoplasms 4 Hodgkin Disease 3 Sarcoma 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Burkitt Lymphoma 2 Triple Negative Breast Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Seminoma 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Osteosarcoma 1 Neoplasm Metastasis 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

pembrolizumab 36 Nivolumab 20 Gemcitabine 18 Paclitaxel 17 Cyclophosphamide 17 Capecitabine 16 fludarabine 11 aldesleukin 11 Ipilimumab 11 130-nm albumin-bound paclitaxel 10 Docetaxel 9 Trastuzumab 8 Albumin-Bound Paclitaxel 8 Radiosurgery 7 Interleukin-2 7 Biopsy 7 Bevacizumab 7 fludarabine phosphate 6 Temozolomide 6 Specimen Handling 6 Irinotecan 6 Fluorouracil 6 Cisplatin 6 Cetuximab 6 Carboplatin 6 avelumab 5 Radiotherapy 5 Pemetrexed 5 Oxaliplatin 5 Magnetic Resonance Spectroscopy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01879085 2022-09-21

GemTax

University of Pittsburgh

Phase 1/2 Completed

37 enrolled 17 charts

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡